TW200640922A - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
TW200640922A
TW200640922A TW095101705A TW95101705A TW200640922A TW 200640922 A TW200640922 A TW 200640922A TW 095101705 A TW095101705 A TW 095101705A TW 95101705 A TW95101705 A TW 95101705A TW 200640922 A TW200640922 A TW 200640922A
Authority
TW
Taiwan
Prior art keywords
compounds
kinases
pharmaceutical compounds
activity
novel
Prior art date
Application number
TW095101705A
Other languages
Chinese (zh)
Inventor
Valerio Berdini
Adrian Liam Gill
Eva Figueroa Navarro
Michael Alistair O'brien
Theresa Rachel Phillips
Gary Trewartha
Andrew James Woodhead
Paul Graham Wyatt
Original Assignee
Astex Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0501480A external-priority patent/GB0501480D0/en
Priority claimed from GB0501748A external-priority patent/GB0501748D0/en
Application filed by Astex Therapeutics Ltd filed Critical Astex Therapeutics Ltd
Publication of TW200640922A publication Critical patent/TW200640922A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to pyrazole compounds that inhibit or modulate the activity of Cyclin Dependent Kinase (CDK) and Glycogen Synthase Kinases (GSK) kinases, to the use of the compounds in the treatment or prophylaxis of disease states or conditions mediated by the kinases, and to novel compounds having kinase inhibitory or modulating activity. Also provided are pharmaceutical compositions containing the compounds and novel chemical intermediates.
TW095101705A 2005-01-21 2006-01-17 Pharmaceutical compounds TW200640922A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US64621705P 2005-01-21 2005-01-21
GB0501480A GB0501480D0 (en) 2005-01-22 2005-01-22 Pharmaceutical compounds
GB0501748A GB0501748D0 (en) 2005-01-27 2005-01-27 Pharmaceutical compounds
US65133905P 2005-02-09 2005-02-09

Publications (1)

Publication Number Publication Date
TW200640922A true TW200640922A (en) 2006-12-01

Family

ID=45699652

Family Applications (3)

Application Number Title Priority Date Filing Date
TW095101705A TW200640922A (en) 2005-01-21 2006-01-17 Pharmaceutical compounds
TW095101695A TW200637858A (en) 2005-01-21 2006-01-17 Pharmaceutical compounds
TW095101704A TW200639170A (en) 2005-01-21 2006-01-17 Pharmaceutical compounds

Family Applications After (2)

Application Number Title Priority Date Filing Date
TW095101695A TW200637858A (en) 2005-01-21 2006-01-17 Pharmaceutical compounds
TW095101704A TW200639170A (en) 2005-01-21 2006-01-17 Pharmaceutical compounds

Country Status (3)

Country Link
GT (3) GT200600016A (en)
MY (1) MY139848A (en)
TW (3) TW200640922A (en)

Also Published As

Publication number Publication date
MY139848A (en) 2009-11-30
GT200600014A (en) 2006-08-09
GT200600015A (en) 2006-08-09
TW200637858A (en) 2006-11-01
TW200639170A (en) 2006-11-16
GT200600016A (en) 2006-08-09

Similar Documents

Publication Publication Date Title
WO2006106326A8 (en) Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
WO2006083673A3 (en) Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases
WO2007079164A3 (en) Protein kinase inhibitors
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
MX2009006535A (en) Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors.
MX2010006203A (en) Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases.
MX2009002377A (en) Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase.
GEP20135724B (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes
GEP20125368B (en) Kinase inhibitors
WO2006055831A3 (en) Kinase inhibitors
WO2007109045A8 (en) Heterocyclic organic compounds for the treatment of in particular melanoma
MX2009003734A (en) Pyrazolopyrimidiwes as cyclin dependent kinase inhibitor.
WO2011090738A3 (en) Type ii raf kinase inhibitors
WO2008049123A8 (en) 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases
WO2007067781A3 (en) 9-membered heterobicyclic compounds as inhibitors of protein kinases
EP1841770A4 (en) Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
EP2571876A4 (en) Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
TN2009000128A1 (en) Dihydropyridine derivatives useful as protein kinase inhibitors
MXPA06010904A (en) Tricyclic pyrazole kinase inhibitors.
MXPA05005199A (en) Pyrimidine compounds.
WO2006050109A3 (en) Novel kinase inhibitors
WO2006063302A3 (en) Variants of glycogen synthase kinase 3 and uses thereof
WO2009097287A9 (en) Compounds and compositions as kinase inhibitors
MX2009010047A (en) Chemical compounds.
MY149044A (en) Pyrazolopyrimidines - derivatives as cyclin dependent kinase inhibitors